• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃神经内分泌肿瘤(G-Nets):发病率、预后及生存改善的近期趋势

Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.

作者信息

Yang Zhen, Wang WeiHua, Lu JingFeng, Pan Gaofeng, Pan Zhiyu, Chen Qian, Liu Weiyan, Zhao Yanping

机构信息

Department of General surgery, Minhang Hospital, Fudan University, Minhang, China.

Department of Thoracic surgery, Minhang Hospital, Fudan University, Minhang, China.

出版信息

Cell Physiol Biochem. 2018;45(1):389-396. doi: 10.1159/000486915. Epub 2018 Jan 22.

DOI:10.1159/000486915
PMID:29402806
Abstract

BACKGROUND/AIMS: Gastric neuroendocrine tumors (G-NETs) are uncommon neoplasms that can present with or without clinical symptoms. In this study, we evaluated the incidence, prognosis, and temporal trends of G-NETs.

METHODS

We analyzed all cases of G-NETs registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2014. Incidence was estimated by age and joinpoint analyses. Survival rates were calculated and survival trends over time were evaluated.

RESULTS

A total of 3740 eligible patients were enrolled in the study. G-NETs incidence increased from 0.31 per 1 000 000 patients in 1975 to 4.85 in 2014, with an annual percentage changes (APCs) of 8.9% (95% confidence interval [CI] = 7.7% to 10.21%, P < 0.001, t test (29) from 1975 to 2001 and 3.6% from 2002 to 2014 (95% CI= 2.3% to 4.9%, P < 0.001). For cases diagnosed between 1973 and 1982, five-year survival was 62.8% ± 7.0% (Standard error, SE) and increased to 86.7% ± 0.7% for cases diagnosed between 2003 and 2012 (P < 0.001). Years of diagnosis, gender, age at diagnosis, marital status, grade, tumor size, tumor stage, and surgery performed or not were the strongest predictors of worse survival in both univariate and multivariate analysis (P<0.05).

CONCLUSION

G-NETs are uncommon neoplasms but the incidence is growing. Survival has improved in the past decades. Years of diagnosis, gender, age at diagnosis, marital status, grade, tumor size, tumor stage, and surgery status predict survival in patients with G-NETs.

摘要

背景/目的:胃神经内分泌肿瘤(G-NETs)是一种罕见的肿瘤,可伴有或不伴有临床症状。在本研究中,我们评估了G-NETs的发病率、预后及时间趋势。

方法

我们分析了1973年至2014年监测、流行病学和最终结果(SEER)数据库中登记的所有G-NETs病例。通过年龄和连接点分析估计发病率。计算生存率并评估随时间的生存趋势。

结果

本研究共纳入3740例符合条件的患者。G-NETs的发病率从1975年的每100万患者0.31例增加到2014年的4.85例,1975年至2001年的年百分比变化(APC)为8.9%(95%置信区间[CI]=7.7%至10.21%,P<0.001,t检验(29)),2002年至2014年为3.6%(95%CI=2.3%至4.9%,P<0.001)。对于1973年至1982年诊断的病例,五年生存率为62.8%±7.0%(标准误,SE),而2003年至2012年诊断的病例则增至86.7%±0.7%(P<0.001)。在单因素和多因素分析中,诊断年份、性别、诊断时年龄、婚姻状况、分级、肿瘤大小、肿瘤分期以及是否进行手术是生存预后较差的最强预测因素(P<0.05)。

结论

G-NETs是罕见肿瘤,但发病率正在上升。在过去几十年中,生存率有所提高。诊断年份、性别、诊断时年龄、婚姻状况、分级、肿瘤大小、肿瘤分期和手术状态可预测G-NETs患者的生存情况。

相似文献

1
Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.胃神经内分泌肿瘤(G-Nets):发病率、预后及生存改善的近期趋势
Cell Physiol Biochem. 2018;45(1):389-396. doi: 10.1159/000486915. Epub 2018 Jan 22.
2
Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.胃神经内分泌肿瘤的发病率和生存趋势:SEER 数据库中 3523 例患者的分析。
Eur J Surg Oncol. 2018 Oct;44(10):1628-1633. doi: 10.1016/j.ejso.2018.01.082. Epub 2018 Jan 31.
3
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.美国胃肠胰神经内分泌肿瘤患者总体生存的流行病学趋势及相关因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2124750. doi: 10.1001/jamanetworkopen.2021.24750.
4
Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?十二指肠神经内分泌肿瘤发病率上升:是惰性疾病的偶然发现?
Surgery. 2015 Aug;158(2):466-71. doi: 10.1016/j.surg.2015.03.042. Epub 2015 May 23.
5
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.胰腺神经内分泌肿瘤(PNETs):发病率、预后及近期生存率改善趋势
Ann Oncol. 2008 Oct;19(10):1727-33. doi: 10.1093/annonc/mdn351. Epub 2008 May 30.
6
Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study.胃神经内分泌肿瘤患者的临床病理特征和预后:一项基于人群的研究。
Cancer Med. 2018 Nov;7(11):5359-5369. doi: 10.1002/cam4.1683. Epub 2018 Oct 11.
7
[Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].240例胃神经内分泌肿瘤的临床病理特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jan 25;23(1):38-43. doi: 10.3760/cma.j.issn.1671-0274.2020.01.007.
8
Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.2017 年世界卫生组织分类系统对胃神经内分泌肿瘤的预后价值:单中心经验。
Turk J Gastroenterol. 2020 Feb;31(2):91-98. doi: 10.5152/tjg.2020.18919.
9
Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.神经内分泌肿瘤的最佳预后因素:分级还是分期?一项多学科单中心研究。
Turk J Gastroenterol. 2016 Nov;27(6):509-514. doi: 10.5152/tjg.2016.16391.
10
Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.恶性神经内分泌肿瘤:儿科患者的发病率及预后
Eur J Pediatr Surg. 2013 Oct;23(5):394-9. doi: 10.1055/s-0033-1333643. Epub 2013 Feb 26.

引用本文的文献

1
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective.神经内分泌肿瘤的流行病学见解与生存模式:地域视角
Endocr Oncol. 2025 Aug 5;5(1):e250039. doi: 10.1530/EO-25-0039. eCollection 2025 Jan.
2
The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors.肿瘤微环境在胃肠胰神经内分泌肿瘤中的作用
Int J Mol Sci. 2025 Jun 12;26(12):5635. doi: 10.3390/ijms26125635.
3
A single center retrospective analysis of feasibility of diagnostic endoscopic resection for grade 1 or 2 gastric neuroendocrine tumors.
单中心回顾性分析1级或2级胃神经内分泌肿瘤诊断性内镜切除的可行性。
Sci Rep. 2025 May 10;15(1):16315. doi: 10.1038/s41598-025-99791-2.
4
Construction and validation of a novel prognostic nomogram for patients with poorly differentiated gastric neuroendocrine neoplasms.一种针对低分化胃神经内分泌肿瘤患者的新型预后列线图的构建与验证
World J Clin Oncol. 2025 Apr 24;16(4):102565. doi: 10.5306/wjco.v16.i4.102565.
5
Risk prediction of second primary malignancies in patients with primary gastric neuroendocrine neoplasms: a population-based study.原发性胃神经内分泌肿瘤患者发生第二原发性恶性肿瘤的风险预测:一项基于人群的研究。
Discov Oncol. 2025 Apr 23;16(1):597. doi: 10.1007/s12672-025-02277-w.
6
Multiple pseudoprogressions during ongoing immunotherapy-based treatment of advanced gastric neuroendocrine carcinoma: A case report and review of literature.晚期胃神经内分泌癌基于免疫疗法的治疗过程中出现多次假性进展:一例病例报告及文献综述
World J Gastrointest Oncol. 2025 Mar 15;17(3):102804. doi: 10.4251/wjgo.v17.i3.102804.
7
Rare epithelial gastric cancers: a review of the current treatment knowledge.罕见上皮性胃癌:当前治疗知识综述
Ther Adv Med Oncol. 2025 Jan 24;17:17588359241255628. doi: 10.1177/17588359241255628. eCollection 2025.
8
Clinical Characteristics and Long-term Outcomes of Gastric Neuroendocrine Tumors.胃神经内分泌肿瘤的临床特征与长期预后
Gut Liver. 2025 Mar 15;19(2):189-197. doi: 10.5009/gnl240272. Epub 2025 Jan 3.
9
Epidemiological, Clinical and Biological Hemogram Features in a Cohort of Neuroendocrine Tumor Patients.一组神经内分泌肿瘤患者的流行病学、临床和生物学血常规特征
Curr Health Sci J. 2024 Apr-Jun;50(2):256-266. doi: 10.12865/CHSJ.50.02.11. Epub 2024 Jun 30.
10
Primary coexisting adenocarcinoma of the colon and neuroendocrine tumor of the duodenum: A case report and review of the literature.原发性结肠腺癌合并十二指肠神经内分泌肿瘤:一例病例报告及文献复习
World J Gastrointest Surg. 2024 Aug 27;16(8):2724-2734. doi: 10.4240/wjgs.v16.i8.2724.